Vicki Moore, PhD

Contributing Writer https://www.pulmonologyadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

Lung Cancer

Smoking Cessation Improves Survival Outcomes for Patients With Non-Small Cell Lung Cancer

Vicki Moore, PhD

September 17, 2021

Researchers found links between smoking cessation and survival outcomes among patients who were smokers at the time of non-small cell lung cancer diagnosis.

Targeted and immunotherapies appear to be opening a new frontier in the management of elderly patien

Lung Cancer

Fatigue as a Mortality Predictor in Advanced Cancer

Vicki Moore, PhD

September 14, 2021

Clinically significant fatigue at baseline was identified as a predictive factor for mortality in studies of 2 forms of cancer treated with chemotherapy.

Lung Cancer

Baseline Fatigue as a Predictor of Mortality Outcomes in Prostate and Lung Cancer

Vicki Moore, PhD

August 26, 2021

Clinically significant fatigue at baseline was identified as a predictive factor for mortality in studies of 2 forms of cancer treated with chemotherapy.

Current clinical data can't confirm or deny the association between risk for VTE and testosterone.

Critical Care

Venous Thromboembolism and Lung Ultrasound Findings With COVID-19

Vicki Moore, PhD

August 17, 2021

Researchers sought to determine the link between lung ultrasound findings and the development of VTE in patients with COVID-19.

Lung Cancer

Targetable Genomic Alterations Likely in Younger Patients With Lung Adenocarcinoma

Vicki Moore, PhD

July 15, 2021

Researchers sought to determine the incidence of targetable genomic cancers in patients younger with lung adenocarcinoma.

Lung Cancer

Frequency of Neuronal Autoantibodies, Cognitive Impairment in Patients With Lung Cancer

Vicki Moore, PhD

July 13, 2021

Researchers sought to determine the association between presence of neuronal autoantibodies and cognitive impairment in patients with lung cancer.

An analysis showed that outcomes of SARS-CoV-2 infections can be disproportionately mild in some patient cohorts.

Lung Infection

Incidence of Asymptomatic SARS-CoV-2 Infection in Actively Treated Cancer

Vicki Moore, PhD

January 27, 2021

Researchers sought to determine the incidence of silent infection with SARS-CoV-2 among patients receiving cancer treatment in Italy during the peak of the pandemic.